Intelligence Platform

Patents

Browse 94 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8642081

Chewable, suckable and swallowable tablet containing a calcium-containing compound as an a

TAKEDA NYCOMED AS · Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8618058

Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity

Soricimed Biopharma Inc. · Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8501727

Short acting benzothiazepine calcium channel blockers and uses thereof

Milestone Pharmaceuticals Inc. · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8388930

Diagnosis and assessment of skeletal related disease using calcium 41

The Regents of the University of California · Granted Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8216614

Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosi

The Board of Regents of the University of Texas System · Granted Tue Jul 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8211935

Heterocyclic derivatives for modulation of calcium channels

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8211857

Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity

Soricimed Biopharma Inc. · Granted Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8178076

Diagnosis and assessment of skeletal related disease using calcium 41

The Regents of the University of California · Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8080672

Crystal form of atorvastatin hemi-calcium and processes for preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8007778

Use of calcium binding proteins to improve cardiac contractile function

The Regents of the University of California · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7994178

Crystalline rosuvastatin calcium and compositions thereof for treatment of hyperlipidaemia

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7888384

Heterocyclic derivatives for modulation of calcium channels

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7737177

Processes for preparing crystalline and amorphous mupirocin calcium

TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Tue Jun 15 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7674923

Process for preparing forms of atorvastatin calcium substantially free of impurities

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7662820

Dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon

SanRx Pharmaceuticals, Inc. · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7629005

Pharmaceutical formulation consisting of a plant dry extract with a calcium coating

Bionorica AG · Granted Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7569604

Heterocyclic derivatives for modulation of calcium channels

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7514441

Substituted pyrazolo [1,5-A]pyrimidines as calcium receptor modulating agents

Takeda Pharmaceutical Company Limited · Granted Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7501450

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7488750

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7468444

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7456297

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7396927

Process for preparation of rosuvastatin calcium

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7378496

hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and

The Regents of the University of California · Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted